XFOR x4pharma.com: Forvard narx/daromad multiplikatori
Global siyosiy keskinliklar immun terapiyalarining xalqaro sinovlariga to'sqinlik qilmoqda va komponentlar yetkazib berish zanjirlarini buzmoqda. X4 Pharmaceuticals (XFOR) kompaniyasining prognoz qilingan P/S grafigi bozor kutganlarining beqarorligini aniq tasdiqlaydi, bunda parametr qiymati 18.70 ga tengdir. Shunga qaramay, X4 Pharmaceuticals WHIM sindromiga qarshi kurashish uchun noyob XOLREMDI dori vositasini ishlab chiqmoqda va AQSh huquqiy bazasida faoliyat yuritish ishlanmalarning gumanitar maqomi tufayli sanksiya risklarini minimallashtiradi.
X4 Pharmaceuticals, Inc (XFOR) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- kompaniyaning jami qarzi va likvidligi ko'rsatkichlari:
Jamlagan qarzning xususiy kapitalga nisbati X4 Pharmaceuticals|XFOR - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati X4 Pharmaceuticals|XFOR - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar X4 Pharmaceuticals, Inc|XFOR - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari X4 Pharmaceuticals|Tezkor likvidlik ko‘rsatkichi x4pharma.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
XFOR - Sof foyda|Prognoz qilingan kelajakdagi foyda X4 Pharmaceuticals|XFOR - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati X4 Pharma|XFOR - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati X4 Pharmaceuticals, Inc|XFOR - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) X4 Pharmaceuticals|XFOR - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati x4pharma.com|XFOR - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi X4 Pharmaceuticals
- sotuvlar va tushum bo'yicha ma'lumotlar:
Kompaniyaning fundamental tahlili:X4 Pharmaceuticals, Inc. XFOR
Noyob immun patologiyalariga e'tibor qaratadigan X4 Pharmaceuticals (XFOR) kompaniyasining tadqiqot va ishlanmalar (R&D)ga yo'naltirilgan biznesi uchun forward P/S ko'rsatkichi bozorning kelgusidagi tijorat muvaffaqiyatidan kutayotgan intizorliklari o'lchovi bo'lib xizmat qiladi. Ushbu metrika joriy bozor kapitalizatsiyasini prognoz qilingan daromadlar bilan bog'lab, onko-immunologlar jamoasining innovatsion salohiyatiga berilgan yuqori bahoni aks ettiradi. Kutilayotgan P/S dinamikasini tahlil qilish orqali investor klinik bosqichlardagi yetakchilik va sotuv maqsadlariga erisha olmaslik xavflari o'rtasidagi muvozanatni baholashi mumkin.
X4 Pharmaceuticals kimlar bilan raqobatlashadi
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ABVX: Forvard narx/daromad multiplikatori|ADMA (ADMA Corp) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati Protagonist Therapeutics|Forvard narx/daromad multiplikatori immunovant.com|KNSA - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati GRFS|ADPT - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori Celldex Corp (CLDX)|Sotuvga nisbatan forvard narx Aurinia Pharmaceuticals|Forvard P/S multiplikatori biocryst.com BCRX|Vera Therapeutics - Forvard P/S multiplikatori|DNTH: Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx Pharvaris Corp PHVS|ABCL (AbCellera Corp) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori TRML|Forvard P/S multiplikatori precigen.com|Forvard P/S multiplikatori PHAR|Forvard P/S multiplikatori Nektar Therapeutics Inc (NKTR)|Upstream Bio Corp - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori Zenas Corp ZBIO|IMNM (Immunome, Inc.) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|gossamerbio.com (GOSS) - Forvard narx/daromad multiplikatori|KALV: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Septerna, Inc.|Pieris Pharmaceuticals Inc (PVLA) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori Savara Pharma|RIGL (Rigel Pharmaceuticals) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori anaptysbio.com (ANAB)|Astria Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori enGene Holdings Inc ENGN|RAPT Therapeutics, Inc. - Forvard P/S multiplikatori|JBIO: Narxning prognoz qilingan daromadga nisbati|Aclaris Therapeutics (ACRS) - Narxning prognoz qilingan daromadga nisbati|KYTX (kyvernatx.com) - Narxning prognoz qilingan daromadga nisbati|TLSA: Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori Cabaletta Bio Inc. (CABA)|Kapitalizatsiyaning prognoz qilingan daromadga nisbati Ventyx Bio VTYX|Forvard P/S multiplikatori Theratechnologies, Inc (THTX)|Avalo Therapeutics, Inc (AVTX) - Kelajakdagi narxning daromadga nisbati|eledon.com - Narxning prognoz qilingan daromadga nisbati|AGEN (Agenus Inc.) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|CLYM: Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx Zura Bio Limited ZURA|ATYR (aTyr Pharmaceuticals) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati Adagene Inc ADAG|Forvard P/S multiplikatori Ikena Oncology, Inc.|Shattuck Labs, Inc. (STTK) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori equilliumbio.com (EQ)|Forvard P/S multiplikatori CNTB (Connect Biopharma Holdings Limited)|Immunic Therapeutics - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx Atara Biotherapeutics Inc (ATRA)|IFRX: Narxning prognoz qilingan daromadga nisbati|ACET (adicetbio.com) - Forvard narx/daromad multiplikatori|Celularity (CELU) - Forvard P/S multiplikatori|INMB (INmune Bio Corp) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Barinthus Biotherapeutics Corp (BRNS)|Kezar Life Sciences (KZR) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori sabbiotherapeutics.com (SABS)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati AKTX|Enlivex Therapeutics Ltd - Narxning prognoz qilingan daromadga nisbati|QTTB: Forvard narx/daromad multiplikatori|GOVX: Narxning prognoz qilingan daromadga nisbati|EDSA (Edesa Biotech, Inc.) - Forvard narx/daromad multiplikatori|Forvard narx/daromad multiplikatori ibioinc.com|CARM (Carisma Therapeutics Inc) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati XTLB|Kapitalizatsiyaning prognoz qilingan daromadga nisbati Bolt Biotherapeutics BOLT|Forvard P/S multiplikatori hcwbiologics.com (HCWB)|APVO: Bozor kapitallashuvining kelajakdagi daromadga nisbati|AIM - Forvard narx/daromad multiplikatori|Aditxt Corp (ADTX) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|GRI (GRI Bio Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|XRTX (XORTX) - Forvard narx/daromad multiplikatori|Vyome Therapeutics - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Revelation Biosciences|indaptusrx.com - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori SCNI|CALI (calcimedica.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AFMD (Affimed N.V.)|Forvard P/S multiplikatori Allakos Inc ALLK|HOOK - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx IGMS (IGM Biosciences, Inc.)|iTeos Therapeutics, Inc. (ITOS) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Ocean Biomedical Inc|TCBP (TC BioPharm (Holdings) PLC) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Third Harmonic Bio Inc
